Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
215 studies found for:    Open Studies | "Psoriasis"
Show Display Options
Rank Status Study
21 Recruiting Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients
Condition: Psoriasis
Interventions: Drug: 1% icotinib hydrochloride cream;   Drug: 2% icotinib hydrochloride cream;   Drug: Placebo
22 Recruiting An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis
Condition: Psoriasis
Interventions: Drug: CNTO 1959 50 mg;   Drug: CTNO 1959 100 mg;   Drug: Placebo 50 mg;   Drug: Placebo 100 mg
23 Recruiting A Registry of Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Intervention:
24 Recruiting Evaluate the Safety and Tolerability of Calcipotriene Foam, 0.005%, in Pediatric Subjects (Ages 2 to 11 Years, Inclusive) With Mild to Moderate Plaque Psoriasis.
Condition: Psoriasis
Intervention: Drug: Calcipotriene 0.005% Foam
25 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:
26 Recruiting Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Secukinumab;   Drug: Ustekinumab
27 Not yet recruiting Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis
Condition: Psoriasis
Intervention: Biological: FURESTEM-CD Inj.
28 Recruiting Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Ixekizumab;   Drug: Placebo
29 Recruiting Observational Study of Apremilast in Patients With Psoriasis in The Netherlands
Condition: Psoriasis
Intervention:
30 Recruiting Oral Psoriasis Treatment Adherence and Intervention Study
Condition: Psoriasis
Intervention: Behavioral: Internet Survey
31 Recruiting Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
Condition: Psoriasis
Interventions: Drug: GSK2982772;   Drug: Placebo
32 Recruiting A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: Apremilast
33 Recruiting A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Condition: Psoriasis
Interventions: Drug: ABBV-553;   Drug: Placebo
34 Recruiting A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions
Condition: Psoriasis
Intervention:
35 Recruiting Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis.
Condition: Chronic Plaque Psoriasis
Interventions: Drug: Bimekizumab;   Other: Placebo
36 Recruiting A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice
Condition: Psoriasis
Intervention: Other: Patient questionnaire
37 Recruiting Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Biological: BCD-057;   Biological: Humira®
38 Not yet recruiting A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp
Condition: Psoriasis
Interventions: Drug: Apremilast;   Other: Placebo
39 Not yet recruiting Proton Pump Inhibitors Use in Patients With Psoriasis
Condition: Psoriasis
Interventions: Drug: esomeprazole;   Drug: desonide
40 Recruiting Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients
Condition: Psoriasis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.